Cargando…
THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer
Colorectal cancer is one of the most common leading causes of death worldwide. Prognostic at an early stage is a useful way that decrease and avoid mortality. Although remarkable progress has been made to investigate the underlying mechanism, the understanding of the complicated carcinogenesis proce...
Autores principales: | Wang, Xue, Zhang, Lei, Li, Hui, Sun, WenJie, Zhang, Honghe, Lai, Maode |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025892/ https://www.ncbi.nlm.nih.gov/pubmed/27632935 http://dx.doi.org/10.1038/srep33366 |
Ejemplares similares
-
Prognostic and Immunological Role of THBS2 in Colorectal cancer
por: Deng, Bin, et al.
Publicado: (2021) -
RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer
por: Fei, Weiqiang, et al.
Publicado: (2017) -
Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer
por: Li, Chen, et al.
Publicado: (2016) -
PMEPA1 induces EMT via a non‐canonical TGF‐β signalling in colorectal cancer
por: Zhang, Lei, et al.
Publicado: (2019) -
HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor
por: Wan, Ledong, et al.
Publicado: (2016)